Status:
COMPLETED
SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
Lead Sponsor:
Shire
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
To evaluate the efficacy of SPD489 for the treatment of executive function impairments (EFI) when used as an adjunct to stable, standard therapy in the setting of partial or full remission from recurr...
Eligibility Criteria
Inclusion
- Adults aged 18-55 with a primary diagnosis of nonpsychotic uni-polar depression
Exclusion
- Current co-morbid psychiatric disorder
Key Trial Info
Start Date :
October 29 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 18 2011
Estimated Enrollment :
143 Patients enrolled
Trial Details
Trial ID
NCT00985725
Start Date
October 29 2009
End Date
April 18 2011
Last Update
June 8 2021
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Valley Research Center
Imperial, California, United States, 92251
2
Pharmacology Research Center
Los Alamitos, California, United States, 90720
3
Excell Research
Oceanside, California, United States, 92056
4
Neuropsychiatric Resesarch Center of Orange County
Santa Ana, California, United States, 92701